A German leading science and technology company, who is currently celebrating its 350th year anniversary, yesterday launched the first of several “Points of Care for Integrated Healthcare Services” units in Kenya. Merck which is incharge of CURAFA which is a pilot unit that will improve access, availability and awareness of primary healthcare services to the communities.
CURAFA points of care are platforms for integrated primary healthcare services, covering clinical and pharmaceutical services including disease awareness and education, along with medicine dispensing and digital health solutions such as telemedicine and disease screening. Insurance and patient financing schemes as well as a facility experience for the local community, including free WiFi access, are part of the offering. As part of the pilot, four more CURAFA points of care will open soon in Machakos, Kiambu and Nairobi county.
Speaking at the official launch of the CURAFA pilot in Kajiado County, Deputy Governor Hon Martin Moshisho welcomed the project saying “societies have varying needs and expectations on healthcare solutions. Collaborations to generate primary healthcare access needs for our community is an important step forward for sustainable development. We kindly thank Merck for the CURAFA initiative.”
“CURAFA is a contribution to the Sustainable Development Goal #3 Good Health and Well-Being and its target of Universal Health Coverage, which is one of the immediate priorities of the government of Kenya” said Francois Feig, Head of Global Business Franchise General Medicine & Endocrinology at Merck´s biopharma business. “At Merck we do understand the importance of quality and care at affordable prices. CURAFA addresses people suffering from inequalities in primary healthcare access aiming to improve patients´ well-being and allowing them to live to their full potential.”
CURAFA fits well with this agenda as it contributes to leapfrogging Kenya´s healthcare system by avoiding the costly development path where cure is the focus instead of prevention. In this regard CURAFA will also leverage eHealth solutions for screening and management of e.g. cardiovascular, metabolic, respiratory and reproductive health.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 53,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.